INS and obesity due to melanocortin 4 receptor deficiency: As we pointed out previously, MCH, in addition to increased feeding, regulates glucose homeostasis and insulin sensitivity, suggesting its potential as a target for the combined treatment for both obesity and type 2 diabetes.